Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 9/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | TP53 | P04637 | 3/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | CTSK | P43235 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 4/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | THRA | P10827 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3164711 | 0.89 | TSHR (0.41) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL28745668 | 0.87 | TSHR (0.39) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL483315 | 0.87 | TSHR (0.39) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL7192136 | 0.87 | TSHR (0.39) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL1132293 | 0.87 | TSHR (0.46) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL11143548 | 0.87 | TSHR (0.39) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL23494129 | 0.86 | TSHR (0.47) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL19456905 | 0.86 | TSHR (0.45) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL1537104 | 0.86 | TSHR (0.57) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL5373235 | 0.86 | TSHR (0.41) | TSHRHPGDALDH1A1TP53HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 366 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260069172-A1 | DIFFUSION LAYER FOR AN ENZYMATIC IN-VIVO SENSOR | ROCHE DIABETES CARE INC (US) | 2026-03-12 | — | — | US | claimed |
| WO-2025024325-A2 | ALL-ACRYLIC TRIBLOCK AND TETRABLOCK COPOLYMERS HAVING A LACTAM MOIETY AND APPLICATIONS THEREOF | ISP INVESTMENTS LLC (US) | 2025-01-30 | — | — | WO | claimed |
| EP-3390535-B1 | PROCESS FOR PRODUCTION OF POLYOXYMETHYLENE INJECTION MOULDED OBJECTS | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2023-05-24 | — | — | EP | claimed |
| EP-3787509-B1 | IMPROVED DIFFUSION LAYER FOR AN ENZYMATIC IN-VIVO SENSOR | HOFFMANN LA ROCHE (CH) | 2022-06-22 | — | — | EP | claimed |
| EP-3787509-A1 | IMPROVED DIFFUSION LAYER FOR AN ENZYMATIC IN-VIVO SENSOR | F. Hoffmann-La Roche AG (CH) | 2021-03-10 | — | — | EP | claimed |
| US-20210045664-A1 | DIFFUSION LAYER FOR AN ENZYMATIC IN-VIVO SENSOR | ROCHE DIABETES CARE, INC. | 2021-02-18 | — | — | US | claimed |
| CN-112074232-A | Improved diffusion layer for in-vivo enzymatic sensors | 豪夫迈·罗氏有限公司 | 2020-12-11 | — | — | CN | claimed |
| EP-3496928-A1 | POLYMER COMPOSITION COMPRISING A (METH)ACRYLIC POLYMER | SABIC Global Technologies B.V. (NL) | 2019-06-19 | — | — | EP | claimed |
| US-20190169339-A1 | POLYMER COMPOSITION COMPRISING A (METH)ACRYLIC POLYMER | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2019-06-06 | — | — | US | claimed |
| EP-3417008-A1 | POLYMER COMPOSITION COMPRISING A (METH)ACRYLIC POLYMER HAVING GOOD OPTICAL PROPERTIES AND HEAT RESISTANCE | SABIC Global Technologies B.V. (NL) | 2018-12-26 | — | — | EP | claimed |
| WO-2017102233-A1 | PROCESS FOR PRODUCTION OF POLYOXYMETHYLENE INJECTION MOULDED OBJECTS | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2017-06-22 | — | — | WO | claimed |
| CN-106226999-A | A kind of method at the rapidly coating photoresists in half tone surface | 村上精密制版（昆山）有限公司 | 2016-12-14 | — | — | CN | claimed |
| US-8648160-B2 | Optical semiconductor sealing material | IDEMITSU KOSAN CO., LTD. (JP) | 2014-02-11 | — | — | US | claimed |
| US-6780507-B2 | Hydrocapsules and method of preparation thereof | ANALYTICAL RESEARCH SYSTEMS, INC. | 2004-08-24 | — | — | US | claimed |
| US-6664318-B1 | Curable composition for solventless hydrophobic resin encapsulation of electronic components comprising non-silicone oligomer having flexible hydrocarbon backbone with reactive functionality, adhesion promoter, optional viscosity modifier | 3M INNOVATIVE PROPERTIES COMPANY | 2003-12-16 | — | — | US | claimed |
| WO-2003059503-A1 | HYDROCAPSULES AND METHOD OF PREPARATION | ANALYTICAL RESEARCH SYSTEMS (US) | 2003-07-24 | — | — | WO | claimed |
| EP-1240251-A1 | ENCAPSULANT COMPOSITIONS WITH THERMAL SHOCK RESISTANCE | 3M Innovative Properties Company (US) | 2002-09-18 | — | — | EP | claimed |
| US-20020050659-A1 | Hydrocapsules and method of preparation thereof | THE WWII BEVERAGE AND PROPELLANTS COMPANY | 2002-05-02 | — | — | US | claimed |
| WO-2001046320-A1 | ENCAPSULANT COMPOSITIONS WITH THERMAL SHOCK RESISTANCE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2001-06-28 | — | — | WO | claimed |
| US-4156034-A | COPOLYMER OF ACRYLIC ESTER AND STYRENE DERIVATIVE AS COATING AGENT | HITACHI, LTD. (JP) | 1979-05-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260069172-A1 | DIFFUSION LAYER FOR AN ENZYMATIC IN-VIVO SENSOR | LDHA, LDHB, BTD | TSHR 1286/4885HPGD 349/4885ALDH1A1 253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.